Protara Therapeutics, Inc. (TARA)
NASDAQ: TARA · Real-Time Price · USD
4.010
-0.250 (-5.87%)
At close: Apr 1, 2025, 4:00 PM
4.080
+0.070 (1.75%)
Pre-market: Apr 2, 2025, 5:40 AM EDT

Protara Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2017 - 2019
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
Market Capitalization
147253213076271
Upgrade
Market Cap Growth
1089.52%1089.52%-29.43%-60.18%-72.06%-
Upgrade
Enterprise Value
-18177-47-70-55106
Upgrade
Last Close Price
4.015.281.882.686.7524.21
Upgrade
PB Ratio
0.841.520.310.300.471.36
Upgrade
P/TBV Ratio
1.521.520.310.300.571.60
Upgrade
Debt / Equity Ratio
0.030.030.080.060.050.01
Upgrade
Quick Ratio
15.5415.5410.7114.7821.3757.84
Upgrade
Current Ratio
15.7115.7111.1715.0121.6658.13
Upgrade
Return on Equity (ROE)
-37.88%-37.88%-47.44%-49.96%-26.17%-34.48%
Upgrade
Return on Assets (ROA)
-23.59%-23.59%-28.36%-16.42%-15.80%-21.07%
Upgrade
Return on Capital (ROIC)
-25.04%-25.04%-29.91%-16.91%-16.07%-21.72%
Upgrade
Earnings Yield
-30.25%-17.59%-189.67%-218.41%-62.30%-12.52%
Upgrade
FCF Yield
-24.33%-14.15%-176.45%-88.01%-46.28%-8.95%
Upgrade
Buyback Yield / Dilution
-81.73%-81.73%-0.64%-0.24%-55.28%-180.66%
Upgrade
Updated Mar 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q